National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$28.00
add to cart

Rights & Permissions

topleft topright

Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism (2001)
Institute of Medicine (IOM)

Citation Manager

. "Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism." Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, DC: The National Academies Press, 2001.

Please select a format:

BibTeX EndNote RefMan


Page
69
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Page 69

1998. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351(9103): 637–641.

Ward B, DeWals, P. 1997. Association of measles infection and the occurrence of chronic inflammatory bowel disease. Can Commun Dis Rep 23(1): 1–6.

Watson JC, Redd SC, Rhodes PH, Hadler SC. 1998. The interruption of transmission of indigenous measles in the United States during 1993. Pediatr Infect Dis J 17(5): 363–6; discussion 366–367.

Welsh RM, McNally JM, Brehm MA, Selin LK. 2000. Consequences of cross-reactiveand bystander CTL responses during viral infections. Virology 270(1): 4–8.

WHO (World Health Organization). The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneva: WHO; 1993.

WHO. 2001. Statement on the Use of the MMR Vaccine. Website: www.who.int/vaccines-diseases/safety/hottop/mmrstatement.htm [Accessed Feb. 2001] .

Wing L. 1997. The autistic spectrum. Lancet 350(9093): 1761–1766.

Woo J. Presentation to Immunization Safety Review Committee. Autism Reports to VAERS: March 8, 2001; Washington, DC.

Page
69